Atlas Trials

Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen

Clinical trial NCT02974361 · COMPLETED

Trial details

NCT number
NCT02974361
Sponsor
Oxford Pharmascience Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2016-12-01
Primary completion
2017-04-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.